MedTrace Logo

Transcranial Pulse Stimulation (TPS) for Alzheimer's Disease (AD)

NCT04333329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-04-03

No results posted yet for this study

Summary

This is a prospective open comprehensive proof-of-principle pilot study.

Conditions

  • Alzheimer Disease

Interventions

DEVICE

NEUROLITH

transcranial pulse stimulation (TPS)

Sponsors & Collaborators

  • Rheintalklinik

    collaborator UNKNOWN

  • Storz Medical AG

    lead INDUSTRY

Principal Investigators

  • Henning Lohse-Busch, MD · Rheintalklinik

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-08
Primary Completion
2017-02-15
Completion
2017-02-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04333329 on ClinicalTrials.gov